1,042
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Does intention to recommend HPV vaccines impact HPV vaccination rates?

, , , , &
Pages 2519-2526 | Received 09 Jul 2014, Accepted 21 Aug 2014, Published online: 30 Oct 2014

References

  • FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus. US. Food and Drug Administration, 2006. (Accessed at http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.);
  • Dillner J, Arbyn M, Dillner L. Translational mini-review series on vaccines: monitoring of human papillomavirus vaccination. Clin Exp Immunol 2007; 148:199–207; PMID:17437418; http://dx.doi.org/10.1111/j.1365-2249.2007.03384.x
  • Foerster V, Murtagh J. Vaccines for prevention of human papillomavirus. Issues Emerg Health Technol 2005; 75:1-4; PMID:16544439
  • Block SL, Nolan T, Sattler C, Barr E, Giacoletti KE, Marchant CD, Castellsagué X, Rusche SA, Lukac S, Bryan JT, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006; 118:2135-45; PMID:17079588; http://dx.doi.org/10.1542/peds.2006-0461
  • Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, Lewis N, Deosaransingh K, Sy L, Ackerson B, et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adol Med 2012; 166:1140-8; http://dx.doi.org/10.1001/archpediatrics.2012.1451
  • FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626-9; PMID:20508593
  • Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, Jacobson RM. Reasons for not vaccinating adolescents: national immunization survey of teens, 2008-2010. Pediatr 2013; 131:645-51; http://dx.doi.org/10.1542/peds.2012-2384
  • Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. MMWR Morb Mortal Wkly Rep 2013; 62:591-5; PMID:23884346
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014; 168:76-82; PMID:24276343; http://dx.doi.org/10.1001/jamapediatrics.2013.2752
  • Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatr 2011; 127:77-84; http://dx.doi.org/10.1542/peds.2010-0812
  • Tissot AM, Zimet GD, Rosenthal SL, Bernstein DI, Wetzel C, Kahn JA. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolescent Health: Off Pub Soc Adolescent Med 2007; 41:119-25; http://dx.doi.org/10.1016/j.jadohealth.2007.05.007
  • Schluterman NH, Terplan M, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine 2011; 29:3767-72; PMID:21440038; http://dx.doi.org/10.1016/j.vaccine.2011.03.032
  • Quinn GP, Murphy D, Malo TL, Christie J, Vadaparampil ST. A national survey about human papillomavirus vaccination: what we didn't ask, but physicians wanted us to know. J Pediatr Adolescent Gynecol 2012; 25:254-8; http://dx.doi.org/10.1016/j.jpag.2012.02.007
  • Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women's Health 2009; 18:1679-86; http://dx.doi.org/10.1089/jwh.2008.1329
  • Constantine NA, Jerman P. Acceptance of Human Papilloma Virus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolescent Health 2007; 40:108-15; http://dx.doi.org/10.1016/j.jadohealth.2006.10.007
  • Daley EM, Vamos CA, Buhi ER, Kolar SK, McDermott RJ, Hernandez N, Fuhrmann HJ. Influences on human papillomavirus vaccination status among female college students. J Women's Health 2010; 19:1885-91; http://dx.doi.org/10.1089/jwh.2009.1861
  • Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Gottlieb SL, Liddon N, Stokley S, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatr 2010; 126:425-33; http://dx.doi.org/10.1542/peds.2009-3500
  • Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010; 28:989-95; PMID:19925899; http://dx.doi.org/10.1016/j.vaccine.2009.10.133
  • Dempsey AF, Schaffer SE, Cohn LM. Follow-up analysis of adolescents partially vaccinated against human papillomavirus. J Adolescent Health: Off Pub Soc Adolescent Med 2012; 50:421-3; http://dx.doi.org/10.1016/j.jadohealth.2011.08.017
  • Sadigh G, Dempsey AF, Ruffin Mt, Resnicow K, Carlos RC. National patterns in human papillomavirus vaccination: an analysis of the National Survey of Family Growth. Hum Vaccin Immunother 2012; 8:234-42; PMID:22414967; http://dx.doi.org/10.4161/hv.18456
  • Patel DA, Zochowski M, Peterman S, Dempsey AF, Ernst S, Dalton VK. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health: J ACH 2012; 60:151-61; http://dx.doi.org/10.1080/07448481.2011.580028
  • Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007; 7:367-73; PMID:17870645; http://dx.doi.org/10.1016/j.ambp.2007.05.010
  • Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012; 30:3546-56; PMID:22480928; http://dx.doi.org/10.1016/j.vaccine.2012.03.063
  • Kouyoumdjian FG, Bailowitz A. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatr Infect Dis J 2011; 30:718-9; PMID:21343841; http://dx.doi.org/10.1097/INF.0b013e3182121426
  • Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatr 2013; 131:1114-24; http://dx.doi.org/10.1542/peds.2012-3122
  • Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012; 30:3112-8; PMID:22425179; http://dx.doi.org/10.1016/j.vaccine.2012.02.034
  • Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatr 2011; 128:830-9; http://dx.doi.org/10.1542/peds.2011-0950
  • Dorell CG, Stokley S, Yankey D, Markowitz LE. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009. Vaccine 2012; 30:503-5; PMID:22119587; http://dx.doi.org/10.1016/j.vaccine.2011.11.042
  • Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine 2012; 30:3534-40; PMID:22480927; http://dx.doi.org/10.1016/j.vaccine.2012.03.067
  • Wong CA, Berkowitz Z, Dorell CG, Anhang Price R, Lee J, Saraiya M. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer 2011; 117:5612-20; PMID:21692069; http://dx.doi.org/10.1002/cncr.26246
  • Schmidt MA, Gold R, Kurosky SK, Daley MF, Irving SA, Gee J, Naleway AL. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011. J Adolescent Health: Off Pub Soc Adolescent Med 2013; 53:637-41; http://dx.doi.org/10.1016/j.jadohealth.2013.08.002
  • Hornik R. Alternative models of behavior change. In: Wasserheit JN, Aral SO, Holmes KK, eds. Research issues in human behavior and sexually transmitted diseases in the AIDS era. Washington, DC: American Society for Microbiology; 1991
  • Armitage C, Conner M. Efficacy of the theory of planned behavior: a meta-analytic review. Br J Soc Psychol 2001; 40:471-99; PMID:11795063; http://dx.doi.org/10.1348/014466601164939
  • Seewald L, Hurley L, Crane LA, Dong F, Stokley S, Daley MF, Barrow J, Babbel C, Dickinson LM, Kempe A. Things are not as bad as they seem: physicians' ability to predict their clinical practice when a new vaccine becomes available. Healthc Policy 2013; 8:71-85; PMID:23968639
  • Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge and attitudes. J Adolescent Health 2005; 37:502-10; http://dx.doi.org/10.1016/j.jadohealth.2005.07.014
  • Allison MA, Dunne EF, Markowitz LE, O'Leary ST, Crane LA, Hurley LP, Stokley S, Babbel CI, Brtnikova M, Beaty BL, et al. HPV vaccination of boys in primary care practices. Acad Pediatr 2013; 13:466-74; PMID:24011749; http://dx.doi.org/10.1016/j.acap.2013.03.006
  • Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 2013; 103:164-9; PMID:22698055; http://dx.doi.org/10.2105/AJPH.2011.300600
  • Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 2013; 103:164-9; PMID:22698055; http://dx.doi.org/10.2105/AJPH.2011.300600
  • Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatr 2014; 133:e835-42; http://dx.doi.org/10.1542/peds.2013-2365
  • Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 2011; 11:74; PMID:21878128; http://dx.doi.org/10.1186/1471-2431-11-74
  • Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatr 2013; 132:1037-46; http://dx.doi.org/10.1542/peds.2013-2037
  • Quinn GP, Murphy D, Malo TL, Christie J, Vadaparampil ST. A national survey about human papillomavirus vaccination: what we didn't ask, but physicians wanted us to know. J Pediatr Adolesc Gynecol 2012; 25:254-8; PMID:22516792; http://dx.doi.org/10.1016/j.jpag.2012.02.007
  • Jim CC, Lee JW, Groom AV, Espey DK, Saraiya M, Holve S, Bullock A, Howe J, Thierry J. Human papillomavirus vaccination practices among providers in Indian health service, tribal and urban Indian healthcare facilities. J Womens Health (Larchmt) 2012; 21:372-8; PMID:22309210; http://dx.doi.org/10.1089/jwh.2011.3417
  • Roblin DW, Ritzwoller DP, Rees DI, Carroll NM, Chang A, Daley MF. The influence of deductible health plans on receipt of the human papillomavirus vaccine series. J Adolescent Health: Off Pub Soc Adolescent Med 2014; 54:275-81; http://dx.doi.org/10.1016/j.jadohealth.2013.12.001
  • Tiro JA, Pruitt SL, Bruce CM, Persaud D, Lau M, Vernon SW, Morrow J, Skinner CS. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine 2012; 30:2368-75; PMID:22108490; http://dx.doi.org/10.1016/j.vaccine.2011.11.031
  • Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi P. National health care visit patterns of adolescents: Implications ofr delivery of new adolescent vaccines. Arch Pediatr Adolescent Med 2007; 161:252-9; http://dx.doi.org/10.1001/archpedi.161.3.252
  • Rand CM, Szilagyi PG, Albertin C, Auinger P. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study. Pediatr 2007; 120:461-6; http://dx.doi.org/10.1542/peds.2007-0012
  • Marlow LA, Waller J, Wardle J. Trust and experience as predictors of HPV vaccine acceptance. Hum Vaccin 2007; 3:171-5; PMID:17622801; http://dx.doi.org/10.4161/hv.3.5.4310
  • Fiks AG, Hunter KF, Localio AR, Grundmeier RW, Alessandrini EA. Impact of immunization at sick visits on well-child care. Pediatr 2008; 121:898-905; http://dx.doi.org/10.1542/peds.2007-2174
  • Lefevere E, Hens N, De Smet F, Van Damme P. Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model. BMC Public Health 2011; 11:470; PMID:21672202; http://dx.doi.org/10.1186/1471-2458-11-470
  • Feemster KA, Winters SE, Fiks AG, Kinsman S, Kahn JA. Pediatricians' intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. J Adolesc Health 2008; 43:408-11; PMID:18809140; http://dx.doi.org/10.1016/j.jadohe-alth.2008.06.012
  • Healy CM, Pickering LK. How to communicate with vaccine-hesitant parents. Pediatr 2011; 127 (Suppl 1):S127-33; http://dx.doi.org/10.1542/peds.2010-1722S
  • Leask J, Kinnersley P, Jackson C, Cheater F, Bedford H, Rowles G. Communicating with parents about vaccination: a framework for health professionals. BMC pediatr 2012; 12:154; PMID:22998654; http://dx.doi.org/10.1186/1471-2431-12-154
  • Ropeik D. How society should respond to the risk of vaccine rejection. Hum Vaccin Immunother 2013; 9:1815-8; PMID:23807359; http://dx.doi.org/10.4161/hv.25250
  • Gowda C, Dempsey AF. The rise (and fall?) of parental vaccine hesitancy. Hum Vaccin Immunother 2013; 9:1755-62; PMID:23744504; http://dx.doi.org/10.4161/hv.25085
  • Gowda C, Schaffer SE, Kopec K, Markel A, Dempsey AF. A pilot study on the effects of individually tailored education for MMR vaccine-hesitant parents on MMR vaccination intention. Hum Vaccin Immunother 2013; 9;
  • Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother 2013; 9:1763-73; PMID:23584253; http://dx.doi.org/10.4161/hv.24657
  • Hagood EA, Mintzer Herlihy S. Addressing heterogeneous parental concerns about vaccination with a multiple-source model: a parent and educator perspective. Hum Vaccin Immunother 2013; 9:1790-4; PMID:23732902; http://dx.doi.org/10.4161/hv.24888
  • Li QH, Lagakos SW. Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event. Stat Med 1997; 16:925-40; PMID:9160489; http://dx.doi.org/10.1002/(SICI)1097-0258(19970430)16:8%3c925::AID-SIM545%3e3.0.CO;2-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.